Capricorn Fund Managers LTD Argenx Se Transaction History

Capricorn Fund Managers LTD

  • $122 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

Apr 18, 2023
SELL
$334.23 - $403.65 $3.04 Million - $3.67 Million
-9,085 Reduced 84.06%
1,723 $641,000
Q4 2022

Jan 17, 2023
BUY
$342.17 - $402.31 $1.03 Million - $1.21 Million
3,001 Added 38.44%
10,808 $4.09 Million
Q3 2022

Nov 09, 2022
BUY
$343.2 - $395.75 $2.68 Million - $3.09 Million
7,807 New
7,807 $2.76 Million

Others Institutions Holding ARGX

# of Institutions
400
Shares Held
30.9M
Call Options Held
376K
Put Options Held
489K
View Full List

About ARGENX SE

ARGX Quotes by TradingView
  • Ticker ARGX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 55,323,800
  • Market Cap $34.8B
  • Description
  • argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany and France. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, ...
More about ARGX
Track This Portfolio

Track Capricorn Fund Managers LTD Portfolio

Follow Capricorn Fund Managers LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capricorn Fund Managers LTD, based on Form 13F filings with the SEC.

News

Stay updated on Capricorn Fund Managers LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email